Tacke, MD, PhD, U., H. Uosukainen, MSci (Pharm), M. Kananen, BSci (Pharm), K. Kontra, Pharm Lic, and H. Pentikäinen, MD. “A Pilot Study about the Feasibility and Cost-Effectiveness of Electronic Compliance Monitoring in Substitution Treatment With buprenorphine—naloxone Combination”. Journal of Opioid Management, vol. 5, no. 6, Jan. 2018, pp. 321-9, doi:10.5055/jom.2009.0032.